Psoriasis: analysis of comorbid pathology

Saranyuk R.V.; Polonikov A.V.

doi:https://doi.org/10.17116/klinderma20252401116

BACKGROUND

Chronic nature of course and presence of systemic inflammation in psoriasis are accompanied by the development of a great number of comorbid disorders, which not only lead to social maladjustment, but also directly affect patients’ survival. For clinicians, diagnostic search of co-occuring disorders in psoriasis during routine practice is often difficult due to their great diversity, different incidence and pronouncement of associations with the main disease.

OBJECTIVE

To study the structure of comorbid disorders in patients with psoriasis.

MATERIAL AND METHODS

A number of patients with the established diagnosis of «psoriasis» equal 509 was investigated from 2018 to 2021. All patients underwent examination with an assessment of the clinical course of psoriasis, the data of medical history were taken into account. The detection and analysis of comorbid disorders was carried out by patient’s clinical examination with further study of medical documentation.

RESULTS

Comorbid disorders have been noted in 224 (44%) patients. Psoriatic arthritis (143/63.8%), arterial hypertension (113/50.4%) and ischemic heart disease (27/12.5%) were the most common impairments. In addition, type II diabetes mellitus (17/7.6%), nephrolithiasis (16/7.1%), chronic glomerulonephritis (16/7.1%) and digestive system lesions with signs of chronic pancreatitis (23/10%) have been registered.

CONCLUSION

The study and analysis of comorbid disorders in patients with psoriasis plays an important role in maintaining health and quality of life of patients. Clinicians should pay attention to the patient’s overall health status, in addition to the pathological process on the skin, with emphasis on possible lesions of the osteoarticular, cardiovascular and other systems.

Keywords:

psoriasis

comorbidity

diabetes mellitus

psoriatic arthritis

cardiovascular diseases

oxidative stress

Authors:

Saranyuk R.V.

Kursk State Medical University;
Society of integrative dermatology

ORCID: 0000-0001-9676-1581

Polonikov A.V.

Kursk State Medical University

ORCID: 0000-0001-6280-247X

Received:

03.06.2024

Accepted:

08.12.2024

Close metadata

References:

Gelfand JM, Mehta NN, Langan SM. Psoriasis and cardiovascular risk: strength in numbers, part II. J InvestDermatol. 2011;131:1007-1010.
National Psoriasis Foundation. Accessed October 1, 2015. https://www.psoriasis.org/cure_known_statistics
Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am AcadDermatol. 1999;41:401-407.
Tejada CS, Mendoza-Sassi RA, Almeida HL Jr, Figueiredo PN, Tejada VF. Impact on the quality of life of dermatological patients in southern Brazil. AnBrasDermatol. 2011;86:1113-1121.
Strauss H. ZurLehre von der neurogenen und der thyreogenenGlykosurie. Dtsch Med Wochenschr. 1897;20:309-312.
Reed WB, Becker SW, Rohde R, et al. Psoriasis and arthritis. Clinicopathologic study. Arch Dermatol.1961;83:541-548.
McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99:469-475.
Oliveira M, Rocha BO, Duarte GV. Psoriasis: classical and emerging comorbidities. AnBrasDermatol. 2015;90(1):9-20. https://doi.org/10.1590/abd1806-4841.20153038
Yumnam D, Kansal N, Kant R. Association of Psoriasis With Thyroid Disorders: A Hospital-Based, Cross-Sectional Study. Cureus. March 09, 2022; 14(3):e22987. https://doi.org/10.7759/cureus.22987
Ahlehoff O, Skov L, Gislason G, et al. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J InternMed. 2013;273(2):197-204. https://doi.org/10.1111/j.1365-2796.2012.02593.x
Takeshita, et al. Psoriasis and comorbid diseases. Epidemiology J Am Acad Dermatol. March 2017;76(3):377-390, https://doi.org/10.1016/j.jaad.2016.07.064
Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735-1741.
Takeshita J, Wang S, Shin DB, et al. Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol. 2015;151:161-169.
Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013;149:84-91.
Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR. Risk of cardiovascular disorders in psoriasis patients: current and future. Am J ClinDermatol. 2013;14:1-7.
Arumugam R, McHugh NJ. Mortality and causes of death in psoriatic arthritis. J Rheumatol Suppl. 2012;89:32-35.
Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, et al. Association between anti-TNF-α therapy and all-cause mortality. PharmacoepidemiolDrugSaf. 2012;21:1311-1320.
Kim N, Thrash B, Menter A. Comorbidities in psoriasis patients. SeminCutan Med Surg. 2010;29:10-15.
Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol. 2003;139:1425-1429.
Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis. J InvestDermatol. 2009;129:2604-2612.
Buslau M, Benotmane K. Cardiovascular complications of psoriasis: Does obstructive sleep apnoea play a role? Acta Derm Venereol.1999;79:234.
Larsson LG, Lundbäck B, Jonsson AC, Lindström M, Jönsson E. Symptoms related to snoring and sleep apnoea in subjects with chronic bronchitis: Report from the obstructive lung disease in Northern Sweden study. Respir Med. 1997;91:5-12.
Dreiher J, Weitzman D, Shapiro J, Davidovici B, Cohen AD. Psoriasis and chronic obstructive pulmonary disease: A case-control study. Br J Dermatol. 2008;159:956-960.
Makredes M, Robinson D, Bala M, Kimball AB. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol. 2009;61(3):405-410. https://doi.org/10.1016/j.jaad.2009.02.015
Wu JJ, Nguyen TU, Poon KYT, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012;67(5):924- 930. https://doi.org/10.1016/j.jaad.2012.04.039
Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn’s disease. J Am Acad Dermatol. 2003;48(6):805-821;quiz 822-824. https://doi.org/10.1067/mjd.2003.540
Sy C, Chen YJ, Tsteng WC, Lin MW, Chen TJ, Hwang CY, et al. Comorbidities profiles among patients with alopecia areata: The importance of onset age, a nationwide population-based study. JAAD. 2011;65(5):949-956. Epub 2011 May 25. https://doi.org/10.1016/j.jaad.2010.08.032
Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK, Chen YC, et al. Comorbidity profiles among patients with bullous pemphigoid: A nationwide population-based study. The British Journal of Dermatology. 2011;165(3):593-599. Epub 2011 Jul 28. https://doi.org/10.1111/j.1365-2133.2011.10386.x
Pinter A, Sarlak M, Zeiner KN, et al. Coprevalence of hidradenitissuppurativa and psoriasis: Detailed demographic, disease severity and comorbidity pattern. Dermatology. 2021;237(5):759-768. https://doi.org/10.1159/000511868
García-Briz MI, García-Ruiz R, Zayas-Gávila AI, et al. Pityriasisrubrapilaris. Something more than a disorder of queratinization? MedicinaCutáneaIbero-Latino-Americana. 2018;46(1):7-12.
Abuabara K, Azfar RS, Shin DB, et al. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163:586-592.
Cottone M, Sapienza C, Macaluso FS, Cannizzaro M. Psoriasis and inflammatory bowel disease. DigDis. 2019;37(6):451-457. https://doi.org/10.1159/000500116
Tsai SY, Chen HJ, Chen C, Lio CF, Kuo CF, Leong KH, et al. Increased Risk of Chronic Fatigue Syndrome Following Psoriasis: A Nationwide Population-Based Cohort Study. J TranslMed. 2019;17(1):154. https://doi.org/10.1186/s12967-019-1888-1
Lee JH, Han K, Gee HY. The Incidence Rates and Risk Factors of Parkinson Disease in Patients With Psoriasis: A Nationwide Population-Based Cohort Study. J AmAcadDermatol. 2020;83(6):1688-1695. https://doi.org/10.1016/j.jaad.2019.07.012
Capo A, Affaitati G, Giamberardino MA, Amerio P. Psoriasis and Migraine. J EurAcadDermatolVenereo.l 2018;32(1):57-61. https://doi.org/10.1111/jdv.14472
Yu S, Yu CL, Huang YC, Tu HP, Lan CE. Risk of Developing Psoriasis in Patients With Schizophrenia: A Nationwide Retrospective Cohort Study. J EurAcadDermatolVenereol. 2017;31(9):1497-1504. https://doi.org/10.1111/jdv.14303
Lima XT, Cueva MA, Lopes EM, Alora MB. Severe Covid-19 Outcomes in Patients With Psoriasis. J EurAcadDermatolVenereol. 2020;34(12):e776- e778. https://doi.org/10.1111/jdv.16867
Ng CY, Huang YH, Chu CF, Wu TC, Liu SH. Risks for Staphylococcus Aureus Colonization in Patients With Psoriasis: A Systematic Review and Meta-Analysis. Br J Dermatol. 2017;177(4):967-977. https://doi.org/10.1111/bjd.15366
Tsai SY, Chen HJ, Lio CF, Ho HP, Kuo CF, Jia X, et al. Increased Risk of Herpes Zoster in Patients With Psoriasis: A Population-Based Retrospective Cohort Study. PloSOn.e 2017;12(8):e0179447. https://doi.org/10.1371/journal.pone.0179447
Zander N, Schäfer I, Radtke M, Jacobi A, Heigel H, Augustin M. Dermatological Comorbidity in Psoriasis: Results From a Large-Scale Cohort of Employees. ArchDermatolRes. 2017;309(5):349-356. https://doi.org/10.1007/s00403-017-1741-4
Reszke R, Białynicki-Birula R, Szepietowski JC. Itch in Psoriasis: A New Look at Well-Known Subject. ActaDermVenereol. 2019;99(4):429-434. https://doi.org/10.2340/00015555-3147
Claßen A, Buhl T, Schubert S, Worm M, Bauer A, Geier J, et al. The Frequency of Specific Contact Allergies Is Reduced in Patients With Psoriasis. Br J Dermatol. 2019;180(2):315-320. https://doi.org/10.1111/bjd.17080
Xie W, Huang H, Ji L, Zhang Z. Maternal and Neonatal Outcomes in Pregnant Women With Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analysis. Rheumatology (Oxford). 2021;60(9):4018-4028. https://doi.org/10.1093/rheumatology/keab357
González-Á lvarez L, Garcıa-Mart ́ ın JM, Garc ́ ıa-Pola MJ. Association Between ́ Geographic Tongue and Psoriasis: A Systematic Review and Meta-Analyses. J OralPatholMed. 2019;48(5):365-372. https://doi.org/10.1111/jop.12840
Egeberg A, Mallbris L, Gislason G, Hansen PR, Mrowietz U. Risk of Periodontitis in Patients With Psoriasis and Psoriatic Arthritis. J EurAcadDermatolVenereol. 2017;31(2):288-293. https://doi.org/10.1111/jdv.13814
Liu JM, Lin CY, Chang FW, Liu YP, Liang CP, Hsu RJ. Increased Risk of Psoriasis Following Scabies Infection: A Nationwide Population-Based Matched-Cohort Study. J Dermatol. 2018;45(3):302-308. https://doi.org/10.1111/1346-8138.14221
Sürücü HA, Aksoy N, Ozgöztas O, Sezen H, Yesilova Y, Turan E. Prolidase Activity in Chronic Plaque Psoriasis Pa-tients. PostepyDermatol. Alergol. 2015;32:82-87.
Chandrashekar L, Kumari GRK, Rajappa M, Revathy G, Munisamy M, Thappa D. 25-hydroxy vitamin D and ischaemia-modified albumin levels in psoriasis and their association with disease severity. Br. J. Biomed. Sci. 2015;72:56-60.
Emre S, Metin A, Demirseren DD, Kilic S, Isikoglu S, Erel O. The Relationship between Oxidative Stress, Smoking and the Clinical Severity of Psoriasis: Oxidative Stress and Smoking in Psoriasis. J. Eur. Acad. Dermatol. Venereol. 2013;27:e370-e375.
Kirmit A, Kader S, Aksoy M, Bal C, Nural C, Aslan O. Trace elements and oxidative stress status in patients with psoriasis. Adv. Dermatol. Allergol. 2020;37:333-339.
Ambrożewicz E, Wójcik P, Wroński A, Łuczaj W, Jastrząb A, Žarković N, Skrzydlewska E. Pathophysiological Alter-ations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients. Cells. 2018;7:159.